BMPRII deficiency impairs apoptosis via the BMPRII-ALK1-BclX (B-cell lymphoma X)-mediated pathway and the Bcl-xL isoform could be a potential biomarker for PAH [25]. This evidence concerns the gene BMPR2 and pulmonary arterial hypertension.